Navigation Links
Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference
Date:5/18/2009

CPF Recognized for Advancing Research and Patient Advocacy Efforts

SAN DIEGO, May 18 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) today announced awards received at the American Thoracic Society's (ATS) International conference in San Diego, Calif. being held this week. The ATS meeting brings together the world's leading pulmonary, critical care and sleep physicians. The CPF received an award for a partner grant program with ATS that, to date, has funded $400,000 in new pulmonary fibrosis research funding. The organization also received a first-time award for its participation in the ATS Public Advisory Roundtable (PAR). The CPF is exhibiting in booth #2921 on "PAR Row" at the International meeting.

The CPF has partnered with the ATS since 2006 to provide peer-reviewed grants for innovative research in PF. To date, the CPF/ATS partner grant program has awarded grants to PF researchers at Johns Hopkins University (Baltimore, MD), Massachusetts General Hospital (Boston, Mass.), Ohio State University Medical Center (Columbus, Ohio) and Vanderbilt University Medical Center (Nashville, Tenn.).

"We are pleased to receive some very prestigious awards from ATS, and we're proud to continue this exciting partnership with ATS," said Mishka Michon, CEO of the CPF.

The CPF received the ATS Foundation's inaugural "Breathing for Life Award" for its participation in the ATS PAR, the patient voice of the ATS. The ATS PAR has created unparalleled synergy with ATS members by involving patients in providing support, shaping public policy and stimulating new research.

Due to the CPF's involvement with ATS and combined efforts to further educate doctors and researchers on PF, the disease is gaining more attention and PF is the subject of an increasing number of high profile sessions at the international conference. Sessions on PF at this year's meeting have included topics ranging from basic research areas in lung stem cells as well as clinical and translational research from bench to bedside.

The CPF also awarded an ATS travel grant, provided to fund a PF researcher's conference travel, to James P. Bridges, Ph.D. from Cincinnati Children's Hospital and Medical Center.

For a schedule of ATS events, please visit http://www.thoracic.org/sections/meetings-and-courses/international-conference/2009/index.html.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring -- known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 19,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. United Concordia and Texas Oral Health Coalition Partner to Offer Free Dental Services
2. Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support
3. Concord Coalition Says New Trustees Report Demonstrates the Importance of Health Care Cost Control
4. PhRMA Statement on Healthcare Reform Coalition
5. Bipartisan Coalition Forms to Call for Chronic Disease to be Key Focus of Health Reform in Indiana and Nationally
6. Latino Coalition Highlights Importance of Personal Health Records At Economic Summit
7. Industry Coalition Advises Against Use of Dietary Supplements as Swine Flu Remedy, Cure
8. Coalition Says On-Site Infectious Medical Waste Treatment Key To Disease Control and Hospital Sustainability During a Pandemic
9. Obama Judicial Nominee Opposed By Coalition of Disability Rights Organizations
10. Coalition of Leaders in Science and Research Commend Obama Administration for Commitment to Medical Innovation During First 100 Days
11. Coalition to Protect Senior Care Applauds Inclusion of Long Term Care in Senate Finance Committee Roundtable Discussion on Health Care Delivery System Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: